Healthcare
Live Price
Offline$2.32
+0.43% today
Window Change
-93.37%
Window
Feb 2, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 96 bars · Feb 2, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Polaryx Therapeutics, Inc. Common Stock (PLYX) is a Healthcare stock with a market cap of $230.00M and listed on NASDAQ. The stock last traded around $2.32 and down 93.4% across the available one-year price window (Feb 2, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -18.8%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -18.8%, free cash flow -53.3% with operating margin 0.0% and ROIC -162.4%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PLYX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PLYX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PLYX Max Drawdown
-93.54%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PLYX and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+0.0%
EPS Growth
-18.8%
Gross Margin
0.0%
Net Margin
0.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.